| Firm |
Analyst |
| Barclay's Capital |
Richard Silver |
| Barclay's Capital |
Ann Trimble |
| BOA/ML |
Gregg Gilbert |
| Buckingham Research |
David Buck |
| Calyon Securities |
David Maris |
| Citi Investment Research |
John Boris |
| Collins Stewart LLC |
Louise Chen |
| Cowen and Company |
Ken Cacciatore |
| Credit Suisse - North America |
Nimish Shah |
| Deutsch Bank North America |
David Steinberg |
| Edward Jones |
Steve Shubitz |
| First Global Stockbroking Ltd. |
Kavita Thomas |
| Goldman Sachs & Co. |
Randall Stanicky |
| Jefferies & Co |
David Windley |
| J.P. Morgan |
Chris Schott |
| Morgan Stanley |
David Risinger |
| Needham & Co |
Elliott Wilbur |
| Oppenheimer & Co |
John Newman |
| Piper Jaffray |
David Amsellem |
| RBC |
Savant Ahmed |
| Sanford C. Bernstein & Co |
Ronny Gal |
| UBS |
Marc Goodman |
| Wells Fargo Securities, LLC |
Michael Tong |
| Israel |
|
| Bank Hapoalim BM |
Gilad Sarig |
| Clal Finance Batucha |
Gal Reiter |
| Excellence Nessuah Securities Ltd. |
Gilad Alper |
| Harel Finance |
Steven Tepper |
| I.B.I. |
Natali Gotlib |
| Leader & Co. Investment House Ltd. |
Yoav Burgan |
| Psagot Ofek Investment |
Limor Gruber |
| |
|
Teva is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Teva's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Teva or its management. Teva does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
|
Back to Top